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Background
« Nanomaterial means a natural, incidental or manufactured material 
containing particles….where…one or more external dimensions is in the size 
range 1 nm-100 nm. »
Source: European Commission Recommendation, 18 October 2011
Many applications include biomedicine, 
food additives, cosmetics, electronics and
industry. 
Medina et al. 2007
Specific properties:
-size 
-high surface area/mass
Due to their specific properties, do manufactured nanomaterials (MNMs) 
pose higher toxicity in biological systems and
risks for environment and human health?
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S a fe ty  e v a lu a t io n  o f  m a n u fa c tu r e d  nanomaterials by 
characterization of their potential genotoxic hazard
(NANOGENOTOX Joint Action (EU)
  Label Crystal Phase Particle 
Size 
Purity 
wt (%) 
Use 
TiO2 
NM102 Anatase 20 95 Photocatalytic effects 
NM103 Rutile (hydrophobic) 20 89 Cosmetics (sun care, colour), pharma, food 
NM104 Rutile (hydrophilic) 20 90 
NM105 85% anatase+15% 
rutile 
22 -  catalysis, heat stabilizer 
SiO2 
NM200 
Synthetic amorphous 
Silica 
20 - Food, processing 
NM201 8-15 - Reinforcement, mechanical and optical properties and process 
NM202 8-15 <99,8 Inks, adhesives, cosmetics, reinforcement, powder process, food, pharma 
NM203 8-20 - Food, cosmetics pharma, reinforcement 
MWCNT 
NM400 
MWCNTs 
9.5 - 
Structural composite and energy applications 
 
NM401 10-30 - 
NM402  - - 
NM403  - - 
NRCWE-006  - >99.5 
NRCWE-007  - - 
 
To evaluate the potential genotoxic
effects of a panel of well-characterized 
MNMs in human lymphocytes
Objectives
, 
In vitro Micronucleus assay (OECD guideline 487)
Fenech, M. Nature Protocols, 2, 1084 - 1104 (2007)
Cultures of PBL from healthy donors 
30 h- exposure to MNMs
-Micronucleated binucleated cells (MNBC) scored in 2000 
binucleate cells (BC);
-Micronucleated mononucleated cells (MNMC) scored in 500 
mononucleated cells (MC)
-The proportion of mono-, bi- and multinucleated cells  in 1000 
cells for cytokinesis-block proliferation index (CBPI)
Methods
 The silicon dioxides do not show genotoxic effects in human lymphocytes.
Similar negative results for MN induction after exposure of lymphocytes to SiO2 NMs have 
been previously described (Downs 2012) although positive results were observed by others 
(Lankoff 2012).
 Some doses of TiO2 NMs and MWCNTs induce clastogenic effects. 
Considering TiO2, the results agree with several evidences showing genotoxic effects in 
human lymphocytes exposed in vitro (Kang 2008; Türkez 2007; Catalán 2011), while only 
one negative result has been published in these cells (Hackenberg 2011). 
While one author reports negative results (Szendi 2008), others showed the genotoxicity of 
MWCNTs in lymphocytes (Cveticanin 2010; Catalán 2011), consistent with the dose-
response observed for NM 403 at low dose-range. The lack of a dose-dependent effect in 
our micronucleus assays at higher dose levels might be explained by the increasing size of 
agglomerates.
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Overall, since no clear dose-response relationships could be disclosed 
for TiO2 and MWCNTs in the present work,
no definitive conclusions about the their genotoxicity can be drawn.
Further ongoing assays, using the same NMs in other in vitro and in vivo 
systems, will allow to improve the knowledge base for the evaluation of 
genotoxic risks associated to the emergence of nanomaterials in human 
environment.  
It is expected that the information about physicochemical characteristics 
generated within Nanogenotox joint action will contribute to understand the 
toxicity determinants of the positive NMs, allowing a “safe-by-design” approach 
to these promising technologies.
Discussion
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